GemVax Raises 52.1 Billion KRW Through Capital Increase and Convertible Bonds
On December 24, GemVax, a KOSDAQ-listed company, announced that it has decided to raise approximately 17 billion KRW in operating funds, including research and development expenses, through a third-party allotment capital increase. The recipients are Gem&Company, the largest shareholder, and Kim Kiho, CEO of GemVax.
On the same day, GemVax also announced that it would raise 35.1 billion KRW in operating funds, including research and development expenses, through the issuance of convertible bonds (CB). The maturity date for the bonds is January 23, 2029.
Hot Picks Today
!["Not Too Delicious": A Summer Health Food Once Reserved for Nobles... 1,800 Years of 'Ham on Melon' [Delicious Stories]](https://cwcontent.asiae.co.kr/asiaresize/93/2026061814120014451_1781759520.jpg)
"Not Too Delicious": A Summer Health Food Once Reserved for Nobles... 1,800 Years of 'Ham on Melon' [Delicious Stories]
- Samsung Electronics' "Special Dividend" Effect: Target Price for Samsung C&T Raised to 630,000 Won... Upward Revisions Continue [Weekend Money]
- "Is It Still a Good Time to Buy Samsung Electronics and SK hynix?"... Market Expert Says "Leadership Concentration Seen 30 Years Ago Too" [Weekend Money]
- Iran Ramps Up Hormuz Pressure... Trump Urges Netanyahu to Ceasefire in Lebanon
- "Addictive and Irresistible: Even Justin Bieber's Wife Is Obsessed... Now 'K-Convenience Stores' Are the Hotspot [K-Holic]"
As a result, GemVax will have raised a total of 52.1 billion KRW in funds.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
